Kidney Cancer Follow-Up Care
Cross-source consensus on Kidney Cancer Follow-Up Care from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Benefits
Risks & contraindications
Highlighted claims
- About 20% to 30% of patients develop recurrence within 5 years after surgery for localised renal cell carcinoma. — Development of the PREDICT-Kidney online tool to promote informed decision-making about kidney cancer follow-up care: a qualitative co-design study
- Recurrence after surgery for localised renal cell carcinoma creates a need for postoperative surveillance. — Development of the PREDICT-Kidney online tool to promote informed decision-making about kidney cancer follow-up care: a qualitative co-design study
- International guidelines recommend tailoring surveillance to individual recurrence risk. — Development of the PREDICT-Kidney online tool to promote informed decision-making about kidney cancer follow-up care: a qualitative co-design study
- Follow-up recommendations remain imprecise and are inconsistently delivered across the UK. — Development of the PREDICT-Kidney online tool to promote informed decision-making about kidney cancer follow-up care: a qualitative co-design study
- Prior research identified improved and personalised surveillance as a priority for patients with kidney cancer follow-up experience. — Development of the PREDICT-Kidney online tool to promote informed decision-making about kidney cancer follow-up care: a qualitative co-design study